Sartorius Aktiengesellschaft (SRT.F)

216.50 -1.50 (-0.69%) As of 08:02AM CEST. Market open.

Sartorius Aktiengesellschaft

Otto-Brenner-Strasse 20
Göttingen 37079
Germany
49 551 308 0
https://www.sartorius.com

Sector(s): Healthcare
Industry: Medical Instruments & Supplies
Full-time employees: 14,614

Key executives

Name	Title	Pay	Exercised	Year born
Dr. Joachim Kreuzburg	Chairman of Executive Board & CEO	1.07M	N/A	1965
Dr. Rene Faber	Head of Bioprocess Solutions Division & Member of Executive Board	613k	N/A	1975
Dr. Alexandra Gatzemeyer	Head of the Lab Products & Services Division and Member of Executive Board	537k	N/A	N/A
Ms. Petra Kirchhoff	Head of Corporate Communications & Investor Relations and Member of Supervisory Board	82k	N/A	1969
Dr. Florian Funck Dipl.Kfm.	CFO & Member of Executive Board	N/A	N/A	1971
Ms. Patricia Spannagel	Head of Quality Assurance - Mechatronics Division Goettingen	N/A	N/A	N/A
Ralf Mohrschladt	Physicist & Head of Supply Chain Management - Germany	N/A	N/A	N/A
Ms. Petra Muller	Head of Investor Relations	N/A	N/A	N/A
Mr. Maurice Phelan	President of Sartorius North America	N/A	N/A	N/A
Dr. Theo Thijssen	President of Environmental Technology Division	N/A	N/A	N/A

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.

Description

Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and services in the United States and internationally. The company offers multi-parallel, benchtop, single-use, stainless steel, cell culture, rocking motion, and microbial bioreactors, and software apps for bioreactors and cell culture shake flask; fermenters; cell culture media products; cellcelector flex, incubator flowbox, nanowell arrays, and capillaries and tips; fluid management products; microbiology products; and Ultrafiltration membrane filters, glass and quartz microfiber filters, clarification, syringeless and in-line filters, lab chromatography, and filters and blotting papers. It also provides live-cell analysis systems, reagents and consumables, support and services, and live-cell imaging and analysis software; contract manufacturing and integration, membranes and devices, weigh cells, and data analytics, as well as connectivity, and pipetting and dispensing modules; electronic and mechanical pipettes, pipette tips, bottle-top dispensers, and pipette controllers and accessories; process automation platform and software, sensors and analyzers, biomolecule analysis tools, and data analytics software; chromatography consumables, columns, and systems; and biolayer interferometry products. In addition, the company offers water purification systems; surface plasmon resonance; lab balances, pipette calibration, mass comparators and metrology, moisture analyzers, equipment manufacturer cells, weights and weight sets, paint mixing solutions, and weighing accessories; and process filtration. Further, the company provides bioprocess consulting and engineering, biologics testing, media and process, instrument, octet service and support, and validation services. It serves the life science research, biopharmaceutical manufacturing, pharmaceutical quality control, cell and gene therapy, and applied industries. Sartorius Aktiengesellschaft was founded in 1870 and is headquartered in Göttingen, Germany.

Corporate governance

Sartorius Aktiengesellschaft’s ISS governance QualityScore as of 1 April 2024 is 9. The pillar scores are Audit: 3; Board: 6; Shareholder rights: 10; Compensation: 9.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.